Do you mean: (A) an overview of how telehealth is performing in Australia in 2025 (policy, usage, quality trends and common pros/cons), or (B) actual consumer reviews / ratings of specific Australian telehealth providers (Healthdirect, GP2U, Instant Clinics, private telehealth companies, etc.)?

Below I’ve put a concise 2025 snapshot (policy changes, usage & experience trends, common positives/negatives, where to read provider reviews) with the most important sources so you can dive deeper or ask me to pull provider‑level ratings/reviews.

Snapshot — Australia telehealth in 2025 (key points)

• Policy and Medicare rules changed in 2025:

  • From 1 March 2025 the MBS clarified telehealth terminology (changing many “telehealth attendances” items to “video attendance”) and updated many MBS items. (servicesaustralia.gov.au)
  • Further changes due 1 November 2025 introduce an “established clinical relationship” requirement for nurse practitioner telehealth MBS items and tie GP telehealth eligibility to MyMedicare registration as an alternative pathway. These tighten access rules for some telehealth rebates while creating a clearer eligibility pathway for registered patients. (AMA.com.au)

• Usage and delivery trends in 2025:

  • Telehealth remains widely used since the pandemic. Telephone consultations are still more common than video, even though official guidance often prefers videoconference when clinically appropriate. Many patients and clinicians still rely on phone for convenience. (canceraustralia.gov.au)
  • Political and funding attention continued in 2025: major parties proposed/pledged expanded after‑hours telehealth and investments in services like Healthdirect. That means scope and access are actively evolving this year. (SBS.com.au)

• Common reported benefits (from studies, sector reporting and stakeholder commentary):

  • Improved access for people in rural/remote areas, reduced travel/time costs, convenience for follow‑ups and some chronic‑disease management. Telehealth also helped workforce flexibility. (canceraustralia.gov.au)

• Common reported problems and concerns:

  • Continuity and quality: regulators and medical bodies raised concerns about continuity of care, which motivated the “established clinical relationship” eligibility tightening. Vulnerable groups (older people, those without digital access, certain specialist first‑consults) may be disadvantaged if rules or funding change. (www1.RACGP.org.au)
  • Equity and cost pressures: rising GP fees and changes to bulk‑billing affect out‑of‑pocket costs and may influence telehealth uptake; some stakeholders warned policy shifts could penalise regional and vulnerable patients. (theaustralian.com.au)

Where to read trustworthy reviews, ratings and deeper analysis

• Official policy/guidance and MBS details: Services Australia / MBS Online (for exact eligibility, item changes and effective dates). Use this for the authoritative rule set. (servicesaustralia.gov.au)
• Professional commentary and clinical perspective: RACGP and AMA news pages (for GP/NP implications and professional guidance). Good for interpreting clinical safety/continuity issues. (www1.RACGP.org.au)
• Consumer/independent reviews and comparisons:
  • CHOICE (consumer advocacy) — may publish comparative reviews and guides.
  • ProductReview.com.au and Google/Apple app reviews — useful for real patient experiences with private telehealth apps/companies.
  • National news outlets (ABC, SBS, The Australian) and health‑sector analysis — useful for broader trends and investigations. (ABC.net.au)

If you want provider‑level reviews (I can fetch live consumer ratings and headlines)

• I can pull recent, specific user reviews and ratings in Australia (2024–2025) for named services such as Healthdirect, GP2U, Instant Consult, TELUS/Teladoc‑partnered services (if operating locally), or commercial after‑hours services. That will include star ratings from ProductReview/Google, recent news items, and any regulator or professional commentary about each provider.
• Tell me which providers you want compared (or say “top 5 Australian telehealth providers 2025”) and I’ll fetch current ratings, common complaints/praises, and links to sources.

Which would you like me to do next: (A) fetch provider‑level consumer reviews now, or (B) dig deeper into policy/regulatory changes and impacts only?